Damage-associated molecular patterns and Toll-like receptors in the tumor immune microenvironment

Hideyuki Yanai1, Sho Hangai1, Tadatsugu Taniguchi1

  • 1Department of Inflammology, Research Center for Advanced Science and Technology, University of Tokyo, 4-6-1 Komaba, Meguro-ku, Tokyo 153-8904, Japan.

Insights

Tumors create a protective tumor immune microenvironment (TIME) by evading immune surveillance. Understanding how damage-associated molecular patterns (DAMPs) and Toll-like receptors (TLRs) shape the TIME is key for developing new cancer immunotherapies.

Area of Science:

  • Immunology
  • Cancer Biology
  • Molecular Biology

Background:

  • Tumors evade immune surveillance, gaining a survival advantage.
  • The tumor immune microenvironment (TIME) is crucial for tumor survival.
  • Tumor-intrinsic factors, including soluble mediators, modulate immune cell function within the TIME.

Purpose of the Study:

  • To investigate how tumor-intrinsic mechanisms, specifically damage-associated molecular patterns (DAMPs) and Toll-like receptors (TLRs), influence the TIME.
  • To understand the role of DAMP-TLR interactions in shaping the TIME to promote tumor growth.
  • To identify potential new strategies for cancer immunotherapy based on these interactions.

Main Methods:

  • Characterization of soluble factors released by tumor cells.
  • Analysis of damage-associated molecular pattern (DAMP) molecules.
  • Investigation of Toll-like receptor (TLR) signaling pathways.
  • Assessment of immune cell modulation within the tumor microenvironment.

Main Results:

  • Tumor cells release DAMP molecules upon necrosis.
  • DAMPs are recognized by innate immune receptors like TLRs.
  • DAMP-TLR interactions stimulate immune cells within the TIME.
  • These interactions contribute to sculpting the TIME to favor tumor progression.

Conclusions:

  • DAMP-TLR interactions are critical in establishing a pro-tumorigenic TIME.
  • Targeting DAMP-TLR signaling pathways presents a promising avenue for cancer immunotherapy.
  • Further research into these mechanisms can lead to novel therapeutic strategies.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.1K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
778
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
819
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.2K